Both scabies and psoriasis are pruritic inflammatory skin diseases. The clinical manifestations are similar and provocation of psoriasis by mite bite was reported. The association between scabies and psoriasis was not investigated before. We conducted this nationwide population-based matched-cohort study to describe if patients with a diagnosis of scabies have a different risk of developing new psoriasis. From the National Health Insurance Research Database of Taiwan, patients with scabies (n = 5137) were identified and matched for age and sex with non-scabies controls (n = 19 142). We tracked them for a 7-year period to identify the incidence of psoriasis. One hundred and ninety (0.8%) patients with newly diagnosed psoriasis were identified; 91 (1.8%) from the scabies group and 99 (0.5%) from the control group. Patients with scabies had a higher risk of subsequent psoriasis, with a crude hazard ratio of 3.45 and an adjusted hazard ratio (aHR) of 3.03 (95% confidence interval, 2.24-4.11). An increased risk for psoriasis among patients with scabies was observed (aHR, 3.03). Immunopathology involving the T-helper 17 cell-mediated inflammatory pathway may contribute to this association. Physicians may consider implementing assessments of psoriatic symptoms in patients with scabies.
INTRODUCTION
Scabies is a troublesome pruritic skin disease which is caused by a parasitic skin infection, the mite Sarcoptes scabiei var. hominis. [1] [2] [3] It is highly contagious and approximately 300 million people around the world suffer from scabies infection annually. 4, 5 People with scabies suffer from a reduction in their quality of life due to intense itching skin lesions caused by the infection. A scabies infection will produce hypersensitivity-like reactions and the subsequent systemic immune responses. 6 Several systemic diseases secondary to scabies infection have been reported before, such as chronic kidney disease and chronic obstructive pulmonary disease (COPD). 7, 8 In relation, the immune-pathological pathway may play a role in the pathophysiology of subsequent systemic diseases.
However, the relationships between scabies and various systemic diseases remain largely unclear. Psoriasis is a chronic inflammatory skin disease with a prevalence rate ranging 0.1-2.9% around the world. 9, 10 It is characterized by excessive growth and aberrant differentiation of keratinocytes. The specific red plaques with well-defined margins and silvery-white scales are typical manifestations. 9 The pathophysiology of psoriasis includes autoimmune and inflammatory reactions, especially activation of the cellular immune system. 11, 12 Similarly, some systemic diseases are more prevalent in patients with psoriasis and the immunepathological pathway contributes to these associations. 11, 13 Both scabies and psoriasis are characterized by pruritic skin lesions. Keipert reported a case report of crusted scabies in a girl with psoriasis in 1986.
14 Skin manifestations in both diseases were so similar that misdiagnosis as the other was common. 15, 16 In addition, both scabies and psoriasis are chronic inflammatory skin diseases. The clinical manifestations and underpinning pathophysiology are similar in these two diseases. An association between scabies and psoriasis may exist and has not been investigated before. The aim, then, of this 14-year population-based cohort study was to describe if patients with a diagnosis of scabies have a different risk of developing new psoriasis. Moreover, this study also compares scabies patients and the matched control subjects in terms of their risks for different severities of psoriasis.
METHODS Data Source
This nationwide population-based study was approved by the Institutional Review Board of the Tri-Service General Hospital (approval no. TSGHIRB NO. B-105-06). The data were extracted from the National Health Insurance Research Database (NHIRD) of Taiwan. The National Health Insurance (NHI) program is a special health insurance system of Taiwan that provides broad health-care coverage to the nation's residents. The NHI program began in 1995 and covered 99.9% of Taiwan's 23 million residents as of the end of 2013. 17 The NHIRD is thus representative of Taiwan's population, and patients' data regarding demographics, medical records, prescription records and medical procedures are included in the database. More specifically, we used the Longitudinal Health Insurance Database 2000 (LHID2000), which is a sub-dataset of the NHIRD comprised of 1 million randomly selected people included in the NHIRD as of 2000. 18 The diagnoses listed in the NHIRD and LHID2000 are based on the International Classification of Diseases, 9th revision, Clinical Modification (ICD-9-CM) system. 19 
Study Participants and Study Design
The study participants were identified from LHID2000 data covering the period from January 2000 to December 2013. The patients newly diagnosed with a scabies infection (ICD-9-CM: 133.0) between January 2001 and December 2006 were enrolled in the study as the scabies group (Fig. 1) . The exclusion criteria for the study included: (i) patients who were diagnosed with scabies before 1 January 2001 (n = 345); (ii) patients with missing medical records (n = 67); (iii) patients younger than 20 years old (n = 1348); and (iv) patients with past history of scabies or psoriasis (n = 60). Finally, 5137 patients with scabies infection were identified and enrolled in the scabies group. The non-scabies control subjects were randomized and matched by age, sex and index year of scabies diagnosed at a ratio of 1:4. The non-scabies control subjects had no previous psoriatic history. The index date for each patient was defined as the date that the diagnosis of scabies was made. On 31 December 2006, 24 281 subjects were enrolled in this study, with 5137 patients in the scabies group and 19 144 patients in the control group. We tracked each subject for a 7-year period following his or her index date to evaluate the subsequent occurrence, if any, of psoriasis (ICD-9-CM: 696.0, 696.1). The diagnosis of psoriasis (ICD-9-CM: 696.0, 696.1) was made by dermatologists with at least one admission or at least two consistent diagnoses in outpatient department visits. Usually, the diagnosis was made by the characteristic history and physical examinations. In addition, the severity of psoriasis was dichotomized and compared. More specifically, the severity of psoriasis was categorized into severe and mild according to treatment patterns. Patients were regarded as having severe psoriasis if they had received systemic therapy and/or phototherapy (i.e. phototherapy, acitretin, methotrexate, cyclosporin, etanercept, adalimumab or ustekinumab) and regarded as having mild psoriasis if they had never received any of the above treatments. This method of categorization has been described in previous studies. [20] [21] [22] [23] One million random sample of NHIRD (2000 NHIRD ( -2006 Subjects with scabies infection (2001) (2002) (2003) (2004) (2005) (2006) n = 6957
Exclusion criteria : The primary outcomes were the incidences of newly diagnosed psoriasis in both patient groups. The secondary outcome was the severity of psoriasis. We analyzed all the medical diagnoses, medical procedures and prescriptions for all of the participants. Covariates including age, monthly income, geographic area of residence, urbanization level and comorbidities were analyzed for both groups. Age was categorized into six groups based on 10-year intervals: 20-29, 30-39, 40-49, 50-59, 60-69, and 70 years and more. Monthly income in New Taiwan Dollars (NTD) was divided into four categories: less than NTD 20 000, 20 000-39 999, 40 000-59 999, and 60 000 or more. The geographic areas were divided into four regions: northern, central, southern and other (eastern and outlying islands). The urbanization levels were classified into four groups. Common comorbidities identified in this study included hypertension (ICD-9-CM: 401-405), hyperlipidemia (ICD-9-CM: 272), diabetes mellitus (DM; ICD-9-CM: 250), coronary heart disease (CHD; ICD-9-CM: 410-414), chronic kidney disease (CKD; ICD-9-CM: 585, 586, 588), chronic liver disease (ICD-9-CM: 456, 571, 572), cerebral vascular accident (CVA; ICD-9-CM: 430-438) and chronic obstructive pulmonary disease (COPD; ICD-9-CM: 491, 492, 496). All of the variables were analyzed and compared.
Statistical Analysis
Student's t-test and the v 2 -test were used to analyze the categorical descriptive data, including demographic characteristics, age, income, geographic area of residence, level of urbanization of residence and comorbidities, and to compare those data for the scabies group and non-scabies control group. The Cox proportional hazards regression model was used to evaluate the risk of subsequent psoriasis and to the independent effects of potential confounders. We determined the hazard ratios (HR) for the two groups accompanied by 95% confidence intervals (CI). Adjustment for potential confounders (including age, sex, income, geographic area, urbanization level and comorbidities) was performed in all models. A two-sided P-value of less than 0.05 was viewed as statistical significance. We used SPSS software version 19.0 (SPSS, Chicago, IL, USA) for statistical analysis and Microsoft â SQL Server â 2008 software (Microsoft, Redmond, WA, USA) for data management.
RESULTS
From January 2001 to December 2006, a total of 24 279 subjects were included in this study. Five thousand and thirtyseven patients with scabies infection were enrolled as the study group, while 19 142 subjects were enrolled as the nonscabies control group. The demographic characteristics of all the participants are listed in Table 1 . There were 2904 males with scabies and 2233 females. The difference in scabies infections between the sexes was not statistically significant. There were two peak incidences among patients aged 70 years and more and patients aged 20-29 years. Most of the patients with a scabies infection had a low income. People who lived in northern Taiwan and urbanized areas represented a greater proportion of the patients with scabies infections. Hypertension, COPD, CVA and DM were the most common comorbidities in patients with scabies. As shown in Table 2 , among the 24 279 study subjects, there were 190 patients who were newly diagnosed with psoriasis during the 7-year follow-up period, including 91 (1.8%) patients from the scabies group and 99 (0.5%) from the control group. Statistically, the incidence of psoriasis was significantly higher in the scabies group than in the control group. An increased risk of psoriasis among the patients with scabies was noted, with a crude HR of 3.45 (95% CI, 2.60-4.59). The Kaplan-Meier curves showed that patients with scabies had significantly higher risks of developing psoriasis than those without scabies ( Fig. 2 , P < 0.001). After adjustment for CHD, coronary heart disease; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CVA, cerebral vascular accident; DM, diabetes mellitus; NTD, New Taiwan Dollars ($US1 = 32 NTD).
potential covariates including age, sex, income and comorbidities, the scabies group still had a higher risk of psoriasis, with an adjusted HR (aHR) of 3.03 (95% CI, 2.24-4.11) ( Table 3) . There was no significant sex difference. Older patients had a lower risk of psoriasis compared with young patients but without statistical significance. Higher rates of psoriasis were found for patients with hypertension, DM, hyperlipidemia, CHD, CKD, chronic liver disease, CVA and COPD, but after adjustment by Cox regression analysis, none of them were statistically significant. Among patients with psoriasis, the majority were mild psoriasis (mild vs severe, 175 vs 15; Table 4 ). Patients with scabies had higher risks of both mild and severe psoriasis (aHR, 3.12 in mild psoriasis and 2.26 in severe psoriasis), but aHR was not statistically significant in severe psoriasis.
DISCUSSION
To the best of our knowledge, this is the first study to investigate the relationship between scabies and psoriasis. There were 5137 patients with scabies and 19 142 non-scabies patients who served as control subjects during the 7-year follow-up period for this study. An increased risk of psoriasis was revealed in the scabies cohort, with an aHR of 3.03 compared with that for the control subjects. In addition, an increased risk of severe psoriasis was also found for the scabies cohort.
The incidence of psoriasis among the patients in this study was 0.8% (190/24 279), which was consistent with the rates indicated by previous reports in Taiwan. 10, 24 Chang et al.
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reported that psoriasis has been estimated to affect 0.23% of the population of Taiwan which is similar to the prevalence in other Mongoloid races, but lower than that reported in Figure 2 . Kaplan-Meier curves of incidence of psoriasis and scabies. Each variable was adjusted for every other variable. *P < 0.05 for comparison between patients with two groups. **P < 0.001 for comparison between patients with two groups. CHD, coronary heart disease; CI, confidence interval; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CVA, cerebral vascular accident; DM, diabetes mellitus; HR, hazard ratio; NTD, New Taiwan Dollars ($US1 = 32 NTD).
Caucasians. The present study indicates an increased risk of psoriasis in patients with scabies, which has not been observed before. 15, 16 The interactions between scabies and psoriasis are complicated and some existing evidences provide us hints regarding this association. First, the cause of psoriasis is not fully understood, but a variety of factors may trigger psoriasis including infections, injuries to the skin, stresses and certain medications. Induction of psoriasis by a preceding Streptococcus pyogenes infection has been reported. 25 Meanwhile, S. pyogenes is the most well-documented infection secondary to scabies. 26 Second, Koebner phenomenon refers to psoriatic lesions following trauma and psoriasis provoked by mite bite has been observed. 27 Furthermore, scabies is easily seen in crowded surroundings including nursing homes, hospitals and army facilities. People who live in these crowded places may suffer stress which may trigger psoriasis. 25 Additionally, both scabies and psoriasis are predominant in cold weather. 1, 9, 10, 28 All of the above-mentioned reports provide us clues in the association between scabies and psoriasis. Scabies and psoriasis are both chronic inflammatory skin diseases. The typical characteristic of psoriasis is localized hyperproliferation of keratinocytes. T-cell-mediated hyperproliferation (T-helper [Th]1, Th17 and Th22 cells) and the overexpression of pro-inflammatory cytokines play important roles in the pathophysiology of psoriasis. 13 Pro-inflammatory and These important findings regarding inflammatory cytokines are summarized in Table 5 . Similarly, immune-mediated inflammatory processes after a S. scabiei exposure have also been previously reported. 6, [37] [38] [39] [40] It seems that elevated levels of IL-2, IL-4, IL-6, IL-17 and IFN-c have been demonstrated in both scabies and psoriasis in most previous studies (Table 5) . Specifically, a Th17 cell-mediated inflammatory pathway with production of IL-17 plays an important role in human immunopathology. Elevated IL-17 levels are found in both scabies and psoriatic patients. 11, 13, 36, 38, 40 Cytokine interactions in psoriasis have been reported to activate signal transducer and activator of transcription (STAT)1, STAT3 and nuclear factor-jB transcription factors. 12 IFN-c that have been elevated in scabies have the ability to activate STAT1 pathways. IL-6 and IL-17 as growth factors have the ability to regulate keratinocyte proliferation in psoriatic lesions. 12 Similarities in the underlying pathophysiologies consolidate the association between scabies and psoriasis. In Taiwan, topical treatment of scabies with benzyl benzoate or crotamiton lotion is the first-line treatment and systemic ivermectin is rarely used. Recurrent infection is not uncommon and treatment of all family members and disinfection of contaminated clothing and linens are emphasized. 41 Because detailed microscopic examinations were unavailable in our study, the eradication of mites after treatment could not be validated. The duration of scabies-related risk of psoriasis may persist for 5-7 years (Fig. 2) . Colonization, chronic infection, recurrent infection or incomplete treatment of scabies may contribute to the observed long-term effects. However, psoriasis is a complex disease and the interval between exposure and disease onset may vary greatly. 25 For example, patients with b-adrenergic receptor blocking agents had a higher risk of psoriasis but the skin lesions mostly appeared 1-18 months after starting to take the drugs. 25 Further studies are required to elucidate the duration of scabies-induced risk. This study elucidated an increased risk of psoriasis among patients with scabies, and several shared immune-mediated inflammatory pathways among scabies and psoriasis may exist. On the other hand, ivermectin, which is used to treat scabies, is reported to have potential benefits in the treatment of psoriasis. 42 Although ivermectin is rarely used in treating scabies in Taiwan. We assumed that early treatment of scabies may slow or block the shared inflammatory processes and lower the subsequent risk of psoriasis. Further prospective studies are needed, however, to investigate this hypothesis. Psoriasis has been found to be associated with diabetes, metabolic syndromes, CKD, cardiovascular disease and COPD in previous studies. 11, [43] [44] [45] Immune-mediated processes are believed to play a role in these associations. Our study reveals increased risks of hypertension, DM, hyperlipidemia, CHD, CKD, chronic liver disease, CVA and COPD among patients with psoriasis. However, after adjustment by Cox regression analysis, the aHR for these diseases were not statistically significant.
The association between scabies and the severity of psoriasis was also investigated in our study. Increased risks of both severe and mild psoriasis were observed in patients with scabies (crude HR of 3.47 for mild psoriasis and 3.29 for severe psoriasis, P < 0.05). After adjustment, the aHR for severe psoriasis was not statistically significant (aHR, 2.26; 95% CI, 0.76-6.71). Further studies are warranted to investigate the impact of scabies on the severity of psoriasis.
A strength of this study is that it was a large-scale nationwide population-based, longitudinal study investigating the association between scabies and psoriasis. However, the study had several limitations. First, all of the diagnoses were made using the ICD-9 coding system and were sourced from an administrative database. Thus, some of the data might have been misinterpreted and some of the diagnoses might have been less exact. The possibility of misdiagnosis between psoriasis and scabies may exist. Detailed results of microscopic examinations were unavailable. The diagnoses of psoriasis in this study were made by specialized dermatologists which minimized the possibility of misdiagnoses. Second, data from laboratory tests are not included in the NHIRD, and further evaluation of inflammatory markers could not be conducted. Laboratory tests may provide useful information for determining the mechanism underlying the relationship between scabies and psoriasis. Third, our population-based study is a retrospective study. In addition, the causal relationship between scabies and psoriasis was not fully identified because of the limitation of the population-based cohort study design. Further prospective studies are thus warranted to investigate the relationship between scabies and psoriasis.
In conclusion, this nationwide population-based study presents evidence indicating a possible relationship between scabies and psoriasis. An increased risk of psoriasis with an aHR of 3.03 was observed in patients with scabies. Immunopathology with a Th17 cell-mediated inflammatory pathway may play a role in this phenomenon. Furthermore, elevated levels of IL-2, IL-4 IL-6, IL-17 and IFN-c have been reported in both scabies and psoriatic patients in the previous published work. Early and aggressive treatment of scabies may decrease the subsequent risk of psoriasis. The occurrence of psoriasis should be considered in patients with refractory scabies. In relation, assessments of psoriatic symptoms should be implemented in the long-term follow up of patients with scabies. 
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